Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
BB Bjorkstrand(Karolinska University Hospital), Gösta Gahrton(Karolinska Institutet), Adrían Alegre(Hospital Universitario de La Princesa), Augustin Ferrant(Cliniques Universitaires Saint-Luc), Ignazio Majolino, Kristina Carlson(Uppsala University Hospital), Michèle Cavo(Unknown), Jane F. Apperley(Hammersmith Hospital), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Per Ljungman(Karolinska University Hospital), Liisa Volin(Helsinki University Hospital), D Samson, Robert Marcus(King's College Hospital), AH Goldstone(Karolinska University Hospital), H. Svensson(Quviq (Sweden)), H. G. Prentice(University of Basel), J. Hermans(Ludwig-Maximilians-Universität München), A. De Laurenzi(Karolinska University Hospital), Kari Remes(Turku University Hospital), LF Verdonck(Radboud University Nijmegen), Joan Bladé(Hospital Clínic de Barcelona)
Cited by 363
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k